Skip to main content
    X

    XORTX Therapeutics Inc (XRTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.06
    +0.02 (+1.92%)

    Market Cap: $2.00M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    XORTX Therapeutics Inc (XRTX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    XORTX Therapeutics (XRTX) has a latest price of $1.06 on Nov 17, 2026, 70.6% below its 52-week high of $3.60. Its price fell 61.9% over the past 12 months. The month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.0%.

    Price Chart

    From Nov 2019 to Oct 2026, its highest month-end close was $215.35 in Sep 2021 and its lowest $1.00 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart XRTX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for XRTX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 47.0%, and over 6 months it fell 54.3%. The month-end price fell 92.7% over the 3 years through Oct 2026, a compound annual decline of 58.1%.

    PeriodChange
    1 month+5.0%
    3 months-47.0%
    6 months-54.3%
    12 months-61.9%
    12 months, with dividends-61.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-92.7%-58.1%
    5 years-99.2%-62.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 50.6%, and its weakest was 2023, when it fell 68.2%.

    YearCloseChange
    2026 through Oct 2026$1.00-64.4%
    2025$2.81-50.2%
    2024$5.65-51.1%
    2023$11.55-68.2%
    2022$36.36-60.6%
    2021$92.26+50.6%
    2020$61.27-11.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 25.3% below its 50-day average of $1.42 and 47.5% below its 200-day average of $2.02.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.06
    52-week high$3.60-70.6%
    52-week low$0.81+30.1%
    50-day average$1.42-25.3%
    200-day average$2.02-47.5%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 97.3%.

    MeasureValue
    1-year beta0.79
    Largest fall, 1 year-73.9%
    Largest fall, 3 years-97.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About XRTX

    What is XRTX's 1-year price change?

    XORTX Therapeutics's price fell 61.9% over the past 12 months. With dividends included, the 12-month total return was -61.9%.

    What is XRTX's 5-year price change?

    XORTX Therapeutics's month-end price fell 99.2% over the 5 years through Oct 2026, a compound annual decline of 62.0%. These figures leave out dividends.

    What is XRTX's 52-week high and low?

    XORTX Therapeutics's 52-week high is $3.60 and its 52-week low is $0.81. Its latest price of $1.06 on Nov 17, 2026 is 70.6% below the high.

    What is XRTX's beta?

    XORTX Therapeutics's 1-year beta against the S&P 500 is 0.79, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 73.9%.

    Is the XRTX chart free?

    Yes. Advanced Charting for XRTX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.